Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

APi (APG) Cash & Equivalents (2019 - 2025)

APi's Cash & Equivalents history spans 7 years, with the latest figure at $912.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 82.77% year-over-year to $912.0 million; the TTM value through Dec 2025 reached $912.0 million, up 82.77%, while the annual FY2025 figure was $912.0 million, 82.77% up from the prior year.
  • Cash & Equivalents reached $912.0 million in Q4 2025 per APG's latest filing, up from $555.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.5 billion in Q4 2021 to a low of $91.0 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $537.8 million, with a median of $470.0 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: crashed 71.11% in 2023, then soared 227.27% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $1.5 billion in 2021, then plummeted by 59.42% to $605.0 million in 2022, then fell by 20.83% to $479.0 million in 2023, then grew by 4.18% to $499.0 million in 2024, then skyrocketed by 82.77% to $912.0 million in 2025.
  • Per Business Quant, the three most recent readings for APG's Cash & Equivalents are $912.0 million (Q4 2025), $555.0 million (Q3 2025), and $432.0 million (Q2 2025).